132 related articles for article (PubMed ID: 8571412)
1. Influence of apolipoprotein E genotype on cerebral amyloid angiopathy in the elderly.
Itoh Y; Yamada M; Suematsu N; Matsushita M; Otomo E
Stroke; 1996 Feb; 27(2):216-8. PubMed ID: 8571412
[TBL] [Abstract][Full Text] [Related]
2. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
3. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.
McCarron MO; Nicoll JA
Ann N Y Acad Sci; 2000 Apr; 903():176-9. PubMed ID: 10818505
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
6. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
Olichney JM; Hansen LA; Hofstetter CR; Lee JH; Katzman R; Thal LJ
Arch Neurol; 2000 Jun; 57(6):869-74. PubMed ID: 10867785
[TBL] [Abstract][Full Text] [Related]
7. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy.
Nicoll JA; Burnett C; Love S; Graham DI; Dewar D; Ironside JW; Stewart J; Vinters HV
Ann Neurol; 1997 Jun; 41(6):716-21. PubMed ID: 9189032
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy.
Greenberg SM; Briggs ME; Hyman BT; Kokoris GJ; Takis C; Kanter DS; Kase CS; Pessin MS
Stroke; 1996 Aug; 27(8):1333-7. PubMed ID: 8711797
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.
Greenberg SM; Rebeck GW; Vonsattel JP; Gomez-Isla T; Hyman BT
Ann Neurol; 1995 Aug; 38(2):254-9. PubMed ID: 7654074
[TBL] [Abstract][Full Text] [Related]
10. Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype.
Leclercq PD; Murray LS; Smith C; Graham DI; Nicoll JA; Gentleman SM
J Neurol Neurosurg Psychiatry; 2005 Feb; 76(2):229-33. PubMed ID: 15654038
[TBL] [Abstract][Full Text] [Related]
11. High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage.
McCarron MO; Nicoll JA
Neurosci Lett; 1998 May; 247(1):45-8. PubMed ID: 9637406
[TBL] [Abstract][Full Text] [Related]
12. Butyrylcholinesterase K variant and cerebral amyloid angiopathy.
Yamada M; Sodeyama N; Itoh Y; Suematsu N; Otomo E; Matsushita M; Mizusawa H
Stroke; 1998 Dec; 29(12):2488-90. PubMed ID: 9836756
[TBL] [Abstract][Full Text] [Related]
13. Association of a polymorphism of the transforming growth factor-beta1 gene with cerebral amyloid angiopathy.
Hamaguchi T; Okino S; Sodeyama N; Itoh Y; Takahashi A; Otomo E; Matsushita M; Mizusawa H; Yamada M
J Neurol Neurosurg Psychiatry; 2005 May; 76(5):696-9. PubMed ID: 15834029
[TBL] [Abstract][Full Text] [Related]
14. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.
Tanskanen M; Lindsberg PJ; Tienari PJ; Polvikoski T; Sulkava R; Verkkoniemi A; Rastas S; Paetau A; Kiuru-Enari S
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):589-99. PubMed ID: 16281907
[TBL] [Abstract][Full Text] [Related]
15. Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.
Ringman JM; Sachs MC; Zhou Y; Monsell SE; Saver JL; Vinters HV
JAMA Neurol; 2014 Jul; 71(7):878-83. PubMed ID: 24797962
[TBL] [Abstract][Full Text] [Related]
16. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease.
Kalaria RN; Cohen DL; Premkumar DR
Ann N Y Acad Sci; 1996 Jan; 777():266-70. PubMed ID: 8624096
[TBL] [Abstract][Full Text] [Related]
18. Cerebral amyloid angiopathy in the elderly: the clinicopathological features, pathogenesis, and risk factors.
Itoh Y; Yamada M
J Med Dent Sci; 1997 Mar; 44(1):11-9. PubMed ID: 9385038
[TBL] [Abstract][Full Text] [Related]
19. APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage.
Nicoll JA; McCarron MO
Amyloid; 2001 Jul; 8 Suppl 1():51-5. PubMed ID: 11676291
[TBL] [Abstract][Full Text] [Related]
20. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant.
Olichney JM; Hansen LA; Galasko D; Saitoh T; Hofstetter CR; Katzman R; Thal LJ
Neurology; 1996 Jul; 47(1):190-6. PubMed ID: 8710076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
